457 related articles for article (PubMed ID: 2563306)
1. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
2. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
Barnett JV; Kuczenski R
J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
[TBL] [Abstract][Full Text] [Related]
4. Homologous desensitization of the beta-adrenergic receptor. Functional integrity of the desensitized receptor from mammalian lung.
Strasser RH; Cerione RA; Codina J; Caron MG; Lefkowitz RJ
Mol Pharmacol; 1985 Sep; 28(3):237-45. PubMed ID: 2993846
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
Ramkumar V; Stiles GL
J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
[TBL] [Abstract][Full Text] [Related]
9. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
10. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
Ryan-Jastrow T; Gnegy ME
J Pharmacol Exp Ther; 1989 Feb; 248(2):626-31. PubMed ID: 2521900
[TBL] [Abstract][Full Text] [Related]
11. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
12. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.
Barnett JV; Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1987 Jul; 242(1):40-7. PubMed ID: 2956412
[TBL] [Abstract][Full Text] [Related]
13. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
[TBL] [Abstract][Full Text] [Related]
14. Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum.
Roseboom PH; Hewlett GH; Gnegy ME
J Pharmacol Exp Ther; 1990 Oct; 255(1):197-203. PubMed ID: 2145422
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogs.
Porter NM; Radulovacki M; Green RD
J Pharmacol Exp Ther; 1988 Jan; 244(1):218-25. PubMed ID: 3335999
[TBL] [Abstract][Full Text] [Related]
16. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
18. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
20. Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin.
Kurose H; Ui M
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):305-18. PubMed ID: 6687224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
